SemaThera competitorsClear all

SemaThera's top competitors include Adaptimmune, Harbour Antibodies, GrayBug and Rebiotix.
SemaThera
SemaThera
SemaThera is a spin-off company focusing on SEMA 3A inhibitors in the treatment of ocular diseases.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Harbour Antibodies
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
GrayBug
GrayBug
GrayBug is a biotechnology company developing technologies to treat eye diseases.
Rebiotix
Rebiotix
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
Founding Date
Founding Date
2016
Founding Date
2008
Founding Date
2006
Founding Date
2011
Founding Date
2011
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Westmount, CA HQ
Locations
Philadelphia, US HQ
Milton, GB
Locations
Newton, US HQ
Locations
Redwood City, US HQ
Baltimore, US
Locations
Saint Paul, US HQ
Employees
Employees
713% decrease
Employees
4007% decrease
Employees
1
Employees
29
Employees
633% decrease
Twitter followers
Twitter followers
104
Twitter followers
3.1 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
83.33%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
304015
Alexa Website Rank
N/A
Alexa Website Rank
280904
Alexa Website Rank
345514
Employee Rating
Employee Rating
N/A
Employee Rating
3.4
Employee Rating
N/A
Employee Rating
4
Employee Rating
2

Funding

Latest funding round
Latest funding round
$ 1m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 3.2m (about 7 years ago)
Latest funding round
$ 80m (about 1 year ago)
Latest funding round
$ 25m (about 6 years ago)
Total funding raised
Total funding raised
$ 1m
Total funding raised
$ 107.5m
Total funding raised
$ 3.2m
Total funding raised
$ 128.5m
Total funding raised
$ 27.8m
For sources of this data, please see the company profile

View company profiles

Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

View company
Harbour Antibodies
HQ
Newton, US
Employees
1

Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

View company
GrayBug
HQ
Redwood City, US
Employees
29

GrayBug is a biotechnology company developing technologies to treat eye diseases.

View company
Rebiotix
HQ
Saint Paul, US
Employees
63↓ 3% decrease

Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.

View company